Why Aurora Cannabis is a Troubled Stock All Over Again

https://www.youtube.com/watch?v=KU1RMaQTOk4 Aurora made news yesterday with a press release full of concerning news. More big writeoffs are coming Pr... Read More»

Cresco Labs Crushes Q2 Estimates, but will Debt Derail the Stock?

Cresco Labs (CNSX: CL), released second-quarter fiscal 2020 earnings today that exceeded street estimates. The company’s revenue came in at $94.3M, almost 25... Read More»

Organigram Had a No Good Very Bad Quarter in Q3 2020

Organigram Inc.(NASDAQ: OGI) (TSX: OGI), released their third quarter fiscal 2020 earnings and there was very little to like. The company saw revenue decline... Read More»

Trulieve CEO Kim Rivers Talks Cannabis and COVID

Grizzle sat down with Trulieve CEO Kim Rivers for an exclusive interview. We caught up with Kim to hear how she is adapting as Coronavirus cases continue to ... Read More»

Waiting for Cannabis Stocks to Rebound? Prepare to Wait a While Longer

https://www.youtube.com/watch?v=8UxsPuPCNP8 The Canadian cannabis sector was absolutely savaged in 2019 as fundamental issues with demand and sky-high expect... Read More»

Curaleaf Q1 Shows Company May Have to Test Market’s Tolerance for More Borrowing

https://www.youtube.com/watch?v=cfqDTFzCkJg UPDATE: After the release of full quarterly financials, we are much more bullish on the company than we were in t... Read More»

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 25th, 2020)

Organigram Announces $49M At-The Market Equity Program Bottom Line: We warned investors last week that Organigram had a cash problem. Now in a release that ... Read More»

Organigram Announces $49M At-The-Market Equity Program

Earlier, we reported on Organigram's (TSE:OGI, NASDAQ:OGI) Q2 2020 earnings which raised some concerns about the company's cash position. Now, as we feared a... Read More»

Marijuana Investor Roundup: Analysis of the Week’s Most Important Events (Apr 18th, 2020)

The Post Roll: Earnings - Aphria, Organigram, Aurora & Valens Bottom Line: In this edition of The Post Roll, we review all the big earnings this week. Wh... Read More»